JP Stock MarketDetailed Quotes

4586 Medrx

Watchlist
  • 83
  • 00.00%
20min DelayMarket Closed Dec 20 15:30 JST
3.93BMarket Cap-3.09P/E (Static)

Medrx Key Stats

EPS
According to the latest financial report of Medrx, the latest earnings per share (TTM) for the company is 1.53. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

Loading...

FCF
Interested in knowing about Medrx's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Medrx shows that the company's current ratio is 52.58, indicating healthy liquidity.

Currency: JPY

Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Medrx, the quick ratio is 51.38, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

Loading...

ROE
Want to learn more about the financial health of Medrx? The latest ROE figure is 3.10%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Medrx, the total asset return on investment (ROA) is 3.02%.

Currency: JPY

Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Medrx's latest financial report to see how their gross margin is doing - currently at 100.00%.

Currency: JPY

Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Medrx, the net profit margin is 29.06%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Loading...